Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice.
Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Daejeon, KR · Author affiliation
Department of Life Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.Location evidence
McLean, US · Author affiliation
Molecular Neurobiology Laboratory, McLean Hospital and Department of Psychiatry, Harvard Medical School, Belmont, MA, USA.Location evidence
US · Author affiliation · country only
Program in Neuroscience, Harvard Medical School, Belmont, MA, USA.Location evidence
AU · Author affiliation · country only
Innovation, AKQA, Victoria, VIC, Australia.Location evidence
Bochum, DE · Author affiliation
Max Planck Institute for Security and Privacy (MPI-SP), Bochum, Germany.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Parkinson's disease (PD), a progressive neurodegenerative disorder, presents complex motor symptoms and lacks effective disease-modifying treatments. Here we show that integrating artificial intelligence (AI) with optogenetic intervention, termed optoRET, modulating c-RET (REarranged during Transfection) signalling, enables task-independent behavioural assessments and therapeutic benefits in freely moving male AAV-hA53T mice. Utilising a 3D pose estimation technique, we developed tree-based AI models that detect PD severity cohorts earlier and with higher accuracy than conventional methods. Employing an explainable AI technique, we identified a comprehensive array of PD behavioural markers, encompassing gait and spectro-temporal features. Moreover, our AI-driven analysis highlights that optoRET effectively alleviates PD progression by improving limb coordination and locomotion and reducing chest tremor. Our study demonstrates the synergy of integrating AI and optogenetic techniques to provide an efficient diagnostic method with extensive behavioural evaluations and sets the stage for an innovative treatment strategy for PD.